Funded Startups in Oceania
Telix Pharmaceuticals’ $600M round (2026-04-14) stands far above the rest of the disclosed amounts, with the next-largest disclosed entries clustered at $3…
Telix Pharmaceuticals’ $600M round (2026-04-14) stands far above the rest of the disclosed amounts, with the next-largest disclosed entries clustered at $315M (AdvanCell, 2026-07-15) and $264M (MoneyMe, 2026-05-14). After that, the concentration tightens: $50M rounds show up repeatedly (Mesoblast 2026-06-24, Partly 2026-06-23, Liquid Instruments 2026-04-28), while the disclosed floor is much smaller at $20K (Number 8 bio, 2026-06-09).
Geographically, the list is heavily Sydney-weighted (14 companies) compared with Melbourne (7) and Perth (6), with Auckland appearing more than once as well (4). Temporally, the displayed 2026 round dates run from 2026-04-09 to 2026-08-13, and the top-of-table activity includes multiple $8M rounds in August (Alloy on 2026-08-11; BioLumic on 2026-08-13). Sector and stage mix are also uneven: AI (8) and biotechnology (7) appear most often, while “Series Unknown” accounts for 28 of the listed rounds (40 disclosed amounts are at least $1M).
Most recent rounds
50 of 1,047997 more funded startups
This page shows the 50 most recent rounds (back to Apr 2026). The full 1,047-company history for this listing opens on a FundedIQ plan.
Unlock all 1,047 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
Which is the largest disclosed round in this Oceania list, and how far ahead is it versus the next-largest disclosed deals?
Telix Pharmaceuticals’ disclosed $600M round closed on 2026-04-14. The next-largest disclosed amounts are $315M (AdvanCell, 2026-07-15) and $264M (MoneyMe, 2026-05-14), so Telix’s figure dwarfs the rest of the disclosed set.
Do any cities dominate the geographic pattern across these recent rounds?
Yes. Sydney is the most frequent location (14 companies), with Melbourne second (7) and Perth third (6); Auckland appears multiple times (4 companies). Examples of Sydney entries include AdvanCell ($315M on 2026-07-15) and Drift Protocol ($100M on 2026-04-16), while Melbourne includes Telix Pharmaceuticals ($600M on 2026-04-14) and Mesoblast ($50M on 2026-06-24).
What do the most recent dated entries suggest about the latest month of activity?
The latest round date shown is 2026-08-13 (BioLumic, $8M). Right behind it, 2026-08-11 includes Alloy at $8M, while 2026-08-10 lists multiple $3M rounds (Class Cover and Fabulate), indicating tighter clustering near $3M–$8M at the top of the table.
What stage label mix shows up most often in this dataset, and how does that relate to disclosed amounts?
“Series Unknown” is the dominant stage label (28 of 50). Disclosed amounts are generally skewed upward: 40 disclosed rounds are at least $1M, while only 7 disclosed rounds are at least $50M (the $50M cluster includes Mesoblast on 2026-06-24, Partly on 2026-06-23, and Liquid Instruments on 2026-04-28).
Are there notable outliers that stand out beyond just size (sector and/or deal profile)?
Yes—besides Telix’s $600M biotechnology funding on 2026-04-14, Drift Protocol’s $100M (2026-04-16) is an additional large disclosed outlier but in “Blockchain and Cryptocurrency.” At the low end, Number 8 bio is a clear small disclosed outlier at $20K on 2026-06-09 in Agriculture and Farming, far below the multi-$M cluster seen across the list.
Know who just raised. Then know who to call.
Every newly funded startup with its round, its investors, and its founders — delivered weekly, or searchable back to 2020.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.